We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Oxygenation System for Adult Cardiac Surgery

By HospiMedica International staff writers
Posted on 18 Apr 2013
An innovative system serves as a patient’s lungs by oxygenating and removing carbon dioxide (CO2) from the blood during various open-heart surgical procedures.

The Affinity Fusion oxygenation system is intended for use during open-heart surgical procedures that require a bloodless, motionless surgical field, as provided by cardiopulmonary bypass (CPB) surgery. More...
Among the features of the system are a proprietary fiber winding process with an interlaced pattern that efficiently filters the blood and removes particles and air, while at the same time oxygenating the blood, and smooth tubular pathways for blood to pass through and a curved venous inlet tube, both of which can reduce blood turbulence during the surgical procedure.

An important feature of the Affinity Fusion is use of Balance Biosurface, a nonheparin, hydrophilic, polymer coating that provides reduced platelet activation and adhesion, and preserves platelet function. The Balance Biosurface coating expands options used by cardiovascular surgery teams for comprehensive strategies to achieve the best possible outcomes for their patients undergoing CPB surgical procedures. Other innovations include proactive air handling, an integrated arterial filter, and a unique design for hemocompatibility.

A new oxygenator system holder gives perfusionists improved flexibility and ease of use in various operating rooms, including those with limited space. Other system enhancements are designed to prevent and remove air bubbles that can enter the blood during the procedure, which may potentially reduce the risk of stroke. The Affinity Fusion oxygenation system is a product of Medtronic (Minneapolis, MN, USA), and has been approved by the US Food and Drug Administration (FDA).

“With so many patients undergoing cardiac surgery each year, Affinity Fusion provides patients with a reliable oxygenation system that is designed to proactively manage air and gently handle blood,” said cardiac surgeon John Liddicoat, MD, senior VP and president of Medtronic’s structural heart division. “This is an important consideration for hospitals that are focused on implementing patient blood management programs and other initiatives that can impact costs associated with transfusions and post-operative complications.”

CPB is a is a form of extracorporeal circulation that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body. The CPB pump, often referred to as a heart-lung machine, is operated by perfusionists.

Related Links:

Medtronic



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.